Taiwan · Delayed Price · Currency is TWD ICARES Medicus Statistics
Total Valuation
ICARES Medicus has a market cap or net worth of TWD 3.34 billion. The enterprise value is 3.61 billion.
| Market Cap | 3.34B |
| Enterprise Value | 3.61B |
Important Dates
The last earnings date was Thursday, March 26, 2026.
| Earnings Date | Mar 26, 2026 |
| Ex-Dividend Date | Aug 22, 2025 |
Share Statistics
ICARES Medicus has 47.52 million shares outstanding. The number of shares has increased by 0.03% in one year.
| Current Share Class | 47.52M |
| Shares Outstanding | 47.52M |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | +1.31% |
| Owned by Insiders (%) | 21.30% |
| Owned by Institutions (%) | 0.25% |
| Float | 23.25M |
Valuation Ratios
The trailing PE ratio is 65.00.
| PE Ratio | 65.00 |
| Forward PE | n/a |
| PS Ratio | 2.95 |
| PB Ratio | 1.69 |
| P/TBV Ratio | 3.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.03, with an EV/FCF ratio of -33.31.
| EV / Earnings | 70.45 |
| EV / Sales | 3.19 |
| EV / EBITDA | 13.03 |
| EV / EBIT | 27.29 |
| EV / FCF | -33.31 |
Financial Position
The company has a current ratio of 2.04, with a Debt / Equity ratio of 0.47.
| Current Ratio | 2.04 |
| Quick Ratio | 1.39 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | 3.38 |
| Debt / FCF | -8.52 |
| Interest Coverage | 5.32 |
Financial Efficiency
Return on equity (ROE) is 0.16% and return on invested capital (ROIC) is 0.28%.
| Return on Equity (ROE) | 0.16% |
| Return on Assets (ROA) | 2.60% |
| Return on Invested Capital (ROIC) | 0.28% |
| Return on Capital Employed (ROCE) | 5.48% |
| Weighted Average Cost of Capital (WACC) | 4.95% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.37 |
| Inventory Turnover | 1.21 |
Taxes
In the past 12 months, ICARES Medicus has paid 64.66 million in taxes.
| Income Tax | 64.66M |
| Effective Tax Rate | 95.47% |
Stock Price Statistics
The stock price has decreased by -40.37% in the last 52 weeks. The beta is 0.37, so ICARES Medicus's price volatility has been lower than the market average.
| Beta (5Y) | 0.37 |
| 52-Week Price Change | -40.37% |
| 50-Day Moving Average | 74.18 |
| 200-Day Moving Average | 90.32 |
| Relative Strength Index (RSI) | 47.21 |
| Average Volume (20 Days) | 29,472 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ICARES Medicus had revenue of TWD 1.13 billion and earned 51.23 million in profits. Earnings per share was 1.08.
| Revenue | 1.13B |
| Gross Profit | 668.18M |
| Operating Income | 128.58M |
| Pretax Income | 67.73M |
| Net Income | 51.23M |
| EBITDA | 235.44M |
| EBIT | 128.58M |
| Earnings Per Share (EPS) | 1.08 |
Balance Sheet
The company has 783.24 million in cash and 923.57 million in debt, with a net cash position of -140.32 million or -2.95 per share.
| Cash & Cash Equivalents | 783.24M |
| Total Debt | 923.57M |
| Net Cash | -140.32M |
| Net Cash Per Share | -2.95 |
| Equity (Book Value) | 1.97B |
| Book Value Per Share | 38.61 |
| Working Capital | 867.88M |
Cash Flow
In the last 12 months, operating cash flow was -58.83 million and capital expenditures -49.52 million, giving a free cash flow of -108.35 million.
| Operating Cash Flow | -58.83M |
| Capital Expenditures | -49.52M |
| Depreciation & Amortization | 106.86M |
| Net Borrowing | -21.85M |
| Free Cash Flow | -108.35M |
| FCF Per Share | -2.28 |
Margins
Gross margin is 59.08%, with operating and profit margins of 11.37% and 4.53%.
| Gross Margin | 59.08% |
| Operating Margin | 11.37% |
| Pretax Margin | 5.99% |
| Profit Margin | 4.53% |
| EBITDA Margin | 20.82% |
| EBIT Margin | 11.37% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.30, which amounts to a dividend yield of 0.43%.
| Dividend Per Share | 0.30 |
| Dividend Yield | 0.43% |
| Dividend Growth (YoY) | 65.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 25.22% |
| Buyback Yield | -0.03% |
| Shareholder Yield | 0.40% |
| Earnings Yield | 1.54% |
| FCF Yield | -3.25% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 22, 2025. It was a forward split with a ratio of 1.1.
| Last Split Date | Aug 22, 2025 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
ICARES Medicus has an Altman Z-Score of 3.36 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.36 |
| Piotroski F-Score | 4 |